Julia Bonavitacola

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Visual acuity and central macular thickness improved in patients with diabetic macular edema who used combined phacoemulsification and intravitreal dexamethasone implants.

Methylprednisolone was more effective in treating thymoma compared with docetaxel but adverse effects were more common.

Patients with unresectable stage III non–small cell lung cancer (NSCLC) had previously received neoadjuvant chemoimmunotherapy.

The maternal morbidity was compared between states that passed laws to regulate providers with states that did not.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The House voted to extend the insurance subsidies under the Affordable Care Act (ACA), but the bill could face problems in the Senate.

Although most clinicians used intraocular pressure (IOP) as a continuous risk factor in glaucoma treatment decisions, the historical cutoff may still be used.

These results were presented during the press briefing ahead of the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium.

The treatment was compared with adagrasib in second- and subsequent-line treatment, with sotarasib coming out on top based on current efficacy data.

Medicare HIV cases are projected to double by 2035, with cumulative costs reaching $195.6 billion and creating critical challenges for federal funding.

Top articles in non–small cell lung cancer (NSCLC) include FDA approvals, improved outcomes due to certain treatments, and updated data presented at conferences.

The most-read content for HIV focused on funding cuts to HIV aid and research and satisfaction with telemedicine for HIV care.

The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.

The top ophthalmology content included FDA approvals, FDA complete response letters, and new associations between cataracts and antioxidant index.

Our conference coverage featured updates on clinical trials testing new treatments for NSCLC, bladder cancer, and breast cancer.

The conference focused on how to improve eye care across the country, including new methods of treating dry eye and utilizing new technologies to catch myopia earlier.

Influenza and COVID-19 are seeing an uptick in incidence as the winter months approach, making protecting vulnerable populations a high priority.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The approval of subcutaneous amivantamab can offer a more accessible means of treatment for patients with non–small cell lung cancer (NSCLC).

Our top conference coverage of the year highlighted findings presented at CROI 2025, ACCC Spring, and EHA, among others.

How strategic partnerships in oncology can enhance patient care by addressing diverse needs through collaboration.

Our top content from the World Conference on Lung Cancer (WCLC) 2025 featured new therapeutic strategies for EGFR+ NSCLC and trial results on amivantamab.

The past year has seen multiple changes in the HIV space that have long-term effects when it comes to ending the epidemic.

Top content from CROI 2025 focused on COVID-19 and HIV, including the safety of a vaccine in people taking antiretroviral therapy.

Artificial intelligence and lung cancer highlighted the top conference coverage from the Association of Cancer Care Centers Annual Meeting in Washington, DC.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The oral medication could be used in gonorrhea that is resistant to antibiotics according to a new phase 3 clinical trial.

Both health care plans brought forward by Republican and Democratic senators, respectively, did not garner enough support from across the aisle.

The incidence of age-related macular degeneration could be linked to handgrip strength according to an analysis of the UK Biobank.